TABLE 2.
Effect of long-term EGCG treatment on plasma biomarkers and liver pathology in C57BL/6J mice fed a high-fat diet for 16 wk (Expt. 2)1
| LF | HF | HFE | |
|---|---|---|---|
| n | 11 | 21 | 21 |
| Plasma biomarkers2 | |||
| Insulin, pmol/L | 74.13 ± 5.17a | 867.24 ± 100b | 353.44 ± 86.21a |
| HOMA-IR | 3.12 ± 0.37a | 74.47 ± 6.47b | 17.41 ± 12.48a |
| Cholesterol, mmol/L | 2.63 ± 0.15a | 5.57 ± 0.13b | 4.21 ± 0.16c |
| Plasma MCP-1, pmol/L | 0.86 ± 0.15a | 6.70 ± 0.99b | 2.04 ± 0.33a |
| Liver pathology | |||
| Liver wt/BW, g/g | 0.036 ± 0.0006a | 0.045 ± 0.002b | 0.035 ± 0.001a |
| Fatty liver incidence | 0/12a | 21/22b | 4/22a |
| Liver triglycerides, μmol/g tissue | 49.69 ± 7.17a | 200.76 ± 15.24b | 61.37 ± 21.34a |
| Plasma ALT, U/L | 13.23 ± 1.50a | 105.21 ± 15.58b | 35.25 ± 5.47a |
Data are presented as means ± SEM. Means in a row with superscripts without a common letter differ, P < 0.05.
Blood samples were taken in food-deprived mice.